BioSpace News Archive

Selvita reported second quarter 2019 financial results and provided a corporate update.

Sigrid Therapeutics AB announces an equity financing round of USD 1.6M.

SAV-IOL is moving forward with the development of the R-TASC Project, the first electronic intraocular lens with real-time autofocus, aimed to fully restore the vision post cataract surgery.

Schrödinger announced the expansion of its multi-year, multi-target drug discovery collaboration with Takeda, as well as Schrödinger’s achievement of the first significant preclinical milestone for the collaboration’s most advanced program.

Bristol-Myers Squibb Company announced that the Phase 3 CheckMate -548 trial evaluating the addition of Opdivo to the current standard of care versus the standard of care alone did not meet one of its primary endpoints, progression-free survival, in patients with newly diagnosed glioblastoma multiforme that is O6-methylguanine-DNA methyltransferase-methylated.

Rocket Pharmaceuticals, Inc. announces that the first patient received investigational therapy in the open-label, Phase 1/2 clinical trial of RP-L201.

In connection with its previously announced public offering of common shares in Canada and the United States, BELLUS Health Inc., announced that it has entered into an underwriting agreement with a syndicate of underwriters comprising Jefferies, Cowen and Guggenheim Securities, as joint book-running managers, Baird, as lead manager, and Bloom Burton Securities, as co-manager

Abionic SA and Genentech announced a strategic agreement to develop and provide an In Vitro Diagnostic (IVD) Asthma Test Panel using Abionic’s POC abioSCOPE® platform in the United States.

TMRW, the automated fertility tissue management system for IVF clinics, announced today that Lori Batta has joined the firm as its Chief Commercial Officer.

InDex Pharmaceuticals Holding AB announced that the list of shareholders has been updated on the homepage with information as of August 30, 2019.